95 related articles for article (PubMed ID: 20004781)
1. Prolonged bronchoprotection against inhaled methacholine by inhaled BI 1744, a long-acting beta(2)-agonist, in patients with mild asthma.
O'Byrne PM; van der Linde J; Cockcroft DW; Gauvreau GM; Brannan JD; Fitzgerald M; Watson RM; Milot J; Davis B; O'Connor M; Hart L; Korducki L; Hamilton AL; Boulet LP
J Allergy Clin Immunol; 2009 Dec; 124(6):1217-21. PubMed ID: 20004781
[TBL] [Abstract][Full Text] [Related]
2. The effect of reducing the fine-particle mass of salmeterol from metered-dose inhalers on bronchodilatation and bronchoprotection against methacholine challenge: a randomized, placebo-controlled, double-blind, crossover study.
Langley SJ; Allen D; McDonnell B; Wheeler N; Sharma RK; Sykes A; Woodcock A
Clin Ther; 2005 Jul; 27(7):1004-12. PubMed ID: 16154479
[TBL] [Abstract][Full Text] [Related]
3. Interpretation of positive results of a methacholine inhalation challenge and 1 week of inhaled bronchodilator use in diagnosing and treating cough-variant asthma.
Irwin RS; French CT; Smyrnios NA; Curley FJ
Arch Intern Med; 1997 Sep; 157(17):1981-7. PubMed ID: 9308510
[TBL] [Abstract][Full Text] [Related]
4. Salbutamol tolerance to bronchoprotection: course of onset.
Stewart SL; Martin AL; Davis BE; Cockcroft DW
Ann Allergy Asthma Immunol; 2012 Dec; 109(6):454-7. PubMed ID: 23176887
[TBL] [Abstract][Full Text] [Related]
5. Tolerance to the bronchoprotective effect of salmeterol 12 hours after starting twice daily treatment.
Drotar DE; Davis EE; Cockcroft DW
Ann Allergy Asthma Immunol; 1998 Jan; 80(1):31-4. PubMed ID: 9475563
[TBL] [Abstract][Full Text] [Related]
6. Beta2-adrenoceptor polymorphism and bronchoprotective sensitivity with regular short- and long-acting beta2-agonist therapy.
Lipworth BJ; Hall IP; Aziz I; Tan KS; Wheatley A
Clin Sci (Lond); 1999 Mar; 96(3):253-9. PubMed ID: 10029561
[TBL] [Abstract][Full Text] [Related]
7. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol.
Kalra S; Swystun VA; Bhagat R; Cockcroft DW
Chest; 1996 Apr; 109(4):953-6. PubMed ID: 8635376
[TBL] [Abstract][Full Text] [Related]
8. Regular formoterol treatment in mild asthma. Effect on bronchial responsiveness during and after treatment.
Yates DH; Sussman HS; Shaw MJ; Barnes PJ; Chung KF
Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 1):1170-4. PubMed ID: 7551366
[TBL] [Abstract][Full Text] [Related]
9. Effect of IVL745, a VLA-4 antagonist, on allergen-induced bronchoconstriction in patients with asthma.
Norris V; Choong L; Tran D; Corden Z; Boyce M; Arshad H; Holgate S; O'Connor B; Millet S; Miller B; Rohatagi S; Kirkesseli S
J Allergy Clin Immunol; 2005 Oct; 116(4):761-7. PubMed ID: 16210048
[TBL] [Abstract][Full Text] [Related]
10. Regular inhaled salbutamol : effect on airway responsiveness to methacholine and adenosine 5'-monophosphate and tolerance to bronchoprotection.
Jokic R; Swystun VA; Davis BE; Cockcroft DW
Chest; 2001 Feb; 119(2):370-5. PubMed ID: 11171711
[TBL] [Abstract][Full Text] [Related]
11. The utility of methacholine airway responsiveness measurements in evaluating anti-asthma drugs.
Inman MD; Hamilton AL; Kerstjens HA; Watson RM; O'Byrne PM
J Allergy Clin Immunol; 1998 Mar; 101(3):342-8. PubMed ID: 9525450
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the dose response to levalbuterol with and without pretreatment with S-albuterol after methacholine-induced bronchoconstriction.
Raissy HH; Harkins M; Esparham A; Kelly HW
Pharmacotherapy; 2007 Sep; 27(9):1231-6. PubMed ID: 17723076
[TBL] [Abstract][Full Text] [Related]
13. Tolerance to the nonbronchodilator effects of inhaled beta 2-agonists in asthma.
O'Connor BJ; Aikman SL; Barnes PJ
N Engl J Med; 1992 Oct; 327(17):1204-8. PubMed ID: 1357551
[TBL] [Abstract][Full Text] [Related]
14. Duration of bronchoprotection of inhaled ipratropium against inhaled methacholine.
Illamperuma C; Davis BE; Fenton ME; Cockcroft DW
Ann Allergy Asthma Immunol; 2009 May; 102(5):438-9. PubMed ID: 19496252
[No Abstract] [Full Text] [Related]
15. The effect of glycopyrronium and indacaterol, as monotherapy and in combination, on the methacholine dose-response curve of mild asthmatics: a randomized three-way crossover study.
Blais CM; Davis BE; Cockcroft DW
Respir Res; 2017 Aug; 18(1):146. PubMed ID: 28768531
[TBL] [Abstract][Full Text] [Related]
16. Effect of an inhaled glucocorticosteroid on mast cell and smooth muscle beta 2 adrenergic tolerance in mild asthma.
Yates DH; Worsdell M; Barnes PJ
Thorax; 1998 Feb; 53(2):110-3. PubMed ID: 9624295
[TBL] [Abstract][Full Text] [Related]
17. Indacaterol, a novel inhaled beta2-agonist, provides sustained 24-h bronchodilation in asthma.
Beeh KM; Derom E; Kanniess F; Cameron R; Higgins M; van As A
Eur Respir J; 2007 May; 29(5):871-8. PubMed ID: 17251236
[TBL] [Abstract][Full Text] [Related]
18. Salbutamol-induced increased airway responsiveness to allergen and reduced protection versus methacholine: dose response.
Bhagat R; Swystun VA; Cockcroft DW
J Allergy Clin Immunol; 1996 Jan; 97(1 Pt 1):47-52. PubMed ID: 8568137
[TBL] [Abstract][Full Text] [Related]
19. Prolonged effect of tiotropium bromide on methacholine-induced bronchoconstriction in asthma.
O'Connor BJ; Towse LJ; Barnes PJ
Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):876-80. PubMed ID: 8887578
[TBL] [Abstract][Full Text] [Related]
20. Correlation between airway inflammation and loss of deep-inhalation bronchoprotection in asthma.
Allen ND; Davis BE; Cockcroft DW
Ann Allergy Asthma Immunol; 2008 Oct; 101(4):413-8. PubMed ID: 18939731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
